|
Market Closed -
Nasdaq
23:00:00 22/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 26.53 USD | +5.87% |
|
-6.35% | -12.56% |
| 10-23 | Rapport Therapeutics Insider Bought Shares Worth $974,278, According to a Recent SEC Filing | MT |
| 10-21 | Health Care Up on Defensive Bias - Health Care Roundup | DJ |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RAPP | Delayed | |
CBOE
| RAPP | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 33.91 | 33.91 | 48.77 |
| Spread/Res. | -21.76% | -21.76% | -45.60% |
| Spread/Supp. | +5.87% | +5.87% | +8.86% |
| Support | 25.06 | 25.06 | 24.37 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RAPP Stock
- Charts Rapport Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
